Funding for this research was provided by:
National Natural Science Foundation of China (81903226)
Article History
Received: 22 October 2022
Accepted: 29 December 2022
First Online: 20 January 2023
Declarations
:
: This is a review article of compliance with ethical standards.
: MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH; Hologenix Inc. Santa Monica, CA; Vielight, Toronto, Canada; JOOVV Inc, Minneapolis-St. Paul MN; Sunlighten, Kansas City, MO; Consulting; USHIO Corp, Japan; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany; Klox Asia, Guangzhou, China. Stockholding: Niraxx Light Therapeutics, Inc., Irvine CA; JelikaLite Corp, New York NY. All other authors declare no competing interests.